ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,92
-0,78%
Dow Jones
40 211,72
0,53%
DAX
18 500,73
-0,53%
Brent Oil
83,10
-1,47%
Bitcoin
63 656,83
-1,84%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
08/04/202112h09Business WireTeva erhält EU-Marktzulassung für Seffalair® Spiromax® und BroPair® Spiromax® (Salmeterol Xinafoate / Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202109h00Business WireTeva receives EU Marketing Authorisation for Seffalair® Spiromax® & BroPair® Spiromax® (salmeterol xinafoate / fluticason...NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202115h42Business WireTeva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202113h30Business WireTeva Canada amplifie son engagement envers les aidants canadiens et présente de nouvelles ressources pour soutenir et améli...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/202113h30InvestorsHub NewsWireAPYP New Apnea AI Solution Could Disrupt $3.7B Sleeping Disorder MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/202121h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/03/202120h46Business WireTeva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressur...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/03/202112h19Dow Jones NewsEuropean Commission Opens Antitrust Investigation Against Teva Over Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/202122h00Business WireTeva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/202114h00Business WireNew Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine TreatmentsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/202122h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/02/202121h59Edgar (US Regulatory)Schedule 13gNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202122h07Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h00Business WireTeva Reports Fourth Quarter and Full Year 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/01/202123h17Business WireTeva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h07Dow Jones NewsCorrection to Drugmakers Raise Prices Article of Jan. 1NYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h01Business WireTeva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results & 2021 Financial Guidance at 8 a.m. ET on Febru...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202122h00Business WireTeva to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202115h12Dow Jones NewsTeva, MedinCell Say Results Positive in Risperidone TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202114h00Business WireTeva & MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable...NYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/202013h52Dow Jones NewsEuropean Commission Fines Teva, Cephalon EUR60.5 Million for Antitrust ViolationNYSE:TEVATeva Pharmaceutical Industries Ltd
05/11/202013h00Business WireTeva Reports Third Quarter 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/202014h00Business WireTeva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® PortfolioNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/202009h14Dow Jones NewsShield Therapeutics: Peer Teva Pharmaceutical Industries Withdraws Oppositions to PatentsNYSE:TEVATeva Pharmaceutical Industries Ltd
15/10/202013h30GlobeNewswire Inc.iBio Announces Appointment of Dr. Alexandra Kropotova to Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202014h00Business WireTeva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfr...NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00Business WireTeva Canada annonce la mise en marché d’Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l’ast...NYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00PR Newswire (Canada)Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthmaNYSE:TEVATeva Pharmaceutical Industries Ltd
05/10/202014h00PR Newswire (Canada)Teva Canada annonce la mise en marché d'Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l'asthme ...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

USOTC
ALIZF
Allianz Ag Muenchen Namen (PK)
NASDAQ
GLSTR
Global Star Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés